2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

Abstract Number: 608

Half Dose Reduction of Methotrexate in Patient with RA Who Achieved Clinical Remission
Abstract Number: 2730

Handgrip Strength Predicts the Risk of Bone Fracture and Severe Adverse Events in Patients with Systemic Necrotizing Vasculitis
Abstract Number: 271

Health Care Disparities for Infectious and Non-Infectious Uveitis in the US
Abstract Number: 967

Health Care Utilization for Musculoskeletal Issues during the Pre-Diagnosis Period in Psoriatic Arthritis – a Population-Based Study
Abstract Number: 275

Health Equity: Access to Rituximab for Patients Comparing Variable Access in a Single Rheumatology Clinic
Abstract Number: 1676

Health Related Quality of Life over Time in a Multi-Ethnic Cohort of Patients with Systemic Lupus Erythematosus and Correlation with Disease Activity and Organ Damage
Abstract Number: 1384

Health-Related Quality of Life in Patients with Ankylosing Spondylitis in the United States
Abstract Number: 2405

Health-Related Quality of Life, Functioning, and Mental Health of Children with Chronic Non-Infectious Uveitis
Abstract Number: 2995

Healthcare Cost of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis
Abstract Number: 2507

Healthcare Resource Utilization in Patients with Secondary Sjögren’s Syndrome Associated with RA Compared with Patients with RA in an Insured Population
Abstract Number: 496

Heart Failure Risk Among Patients with Rheumatoid Arthritis: Association with Anti-Rheumatic Drugs
Abstract Number: 2943

Helping a Non-Urban Community Walk with Ease: A Feasibility Pilot Study of an Arthritis Activity Intervention
Abstract Number: 2640

Hematologic Activity in Systemic Lupus Erythematosus: Is Splenectomy Our Best Choice?
Abstract Number: 1417

Hemophagocytic Lymphohistiocytosis (HLH) Mimickers: CXCL9 As a Potential Biomarker Distinguishing HLH from Other Hyperferritinemic Syndromes
Abstract Number: 2161

Hemophagocytic Syndrome in Adults and Association with Rheumatologic Diagnoses: US National Inpatient Trend over Nine Years
Abstract Number: 1995

Heparan Sulfates from Human Osteoarthritic Cartilage Display Increased Sulfation Pattern, Decrease the Protein Binding Capacity to FGF-2 and Increase the Binding to VEGF and Induce Changes of Human Mesenchymal Stem Cell Behavior
Abstract Number: 736

Herpes Zoster and Disseminated Zoster in Systemic Lupus Erythematosus and Lupus Nephritis: Incidence Rates in Real-World Claims Data
Abstract Number: 2767

Herpes Zoster As a Risk Factor for Polymyalgia Rheumatica: A Population-Based Study
Abstract Number: 2451

Herpes Zoster in Rheumatoid Arthritis. Prospective Single Center Study of 390 RA Patients for 5 YEARS
Abstract Number: 769

Herpes Zoster in Systemic Lupus Erythematosus: Prevalence and Risk Factors
Abstract Number: 885

Herpes Zoster in Tofacitinib Users with and without Concomitant Methotrexate and Glucocorticoids
Abstract Number: L08

High Baseline Serum IL-6 Identifies a Subgroup of Rheumatoid Arthritis Patients with Rapid Joint Damage and Clinical Progression and Predicts Increased Sarilumab Treatment Response
Abstract Number: 135

High Dimensional Analysis By Mass Cytometry and RNA-Sequencing Reveals Altered Frequency and Exhausted Features of CD4 T and MAIT Cells in Systemic Sclerosis
Abstract Number: 2273

High Dose Intravenous Methylorednisolone Induces Rapid Improvement in Severe Non-Infectious Uveitis. a Multicenter Study of 120 Patients
Abstract Number: 2692

High Frequency Ultrasound As a Novel Approach to Quantifying the Digital Microangiopathy of Systemic Sclerosis
Abstract Number: 148

High Level of CD38 Expression in SLE CD8 T Cells Dictates Decreased Cytotoxicity
Abstract Number: 2831

High Need for Anti-TNF Therapy after Withdrawal Strategy in Early Peripheral Spondyloarthritis
Abstract Number: 669

High Prevalence of Axial Spondyloarthritis in Patients with Acute Anterior Uveitis and Chronic Back Pain – Preliminary Results of a Prospective Observational Study
Abstract Number: 243

High Prevalence of Fibromyalgia Among Israel School Teachers
Abstract Number: 2778

High Prevalence of Vascular Surgery and Autoimmune Comorbidity in Takayasu Arteritis
Abstract Number: 1224

High Rates of Conversion and Reversion of Tuberculosis Screening Assays in Rheumatic Patients during Long Term Biologic Treatment
Abstract Number: 1907

High Serum Adiponectin Associates with the Incidence of Rheumatoid Arthritis in Obese Subjects
Abstract Number: 2333

High Serum Uric Acid Protects Against Osteoporosis in Postmenopausal Women: Data from the Korean National Health and Nutrition Examination Survey
Abstract Number: 2761

High-Dose Prednisone Use up to 42 Days Prior to Temporal Artery Biopsy (TAB) Did Not Reduce Yield of Positive Biopsy in the Veterans Health Administration (VHA) Database Cohort
Abstract Number: 1719

High-Throughput Quantitative Histology in Systemic Sclerosis Skin Disease Using Computer Vision
Abstract Number: 1280

Higher Body Fat Percentage in Non-Obese Late-Onset Gout Patients
Abstract Number: 1720

Higher Neutrophil Count Predicts More Severe Skin/Lung Disease and Increased Mortality in Early Systemic Sclerosis
Abstract Number: 712

Higher Prednisolone Dose during Treatment of Tuberculosis Correlates with Mortality during Tuberculosis Treatment in Systemic Lupus Erythematosus Patients: A Retrospective Cohort Study
Abstract Number: 1621

Higher Serum Uric Acid Levels Protect Against Osteoporosis in Patients with Axial Spondyloarthropathy
Abstract Number: 106

Highly Elevated Levels of Anti-Mitochondrial Antibodies in Systemic Lupus Erythematosus and Rheumatoid Arthritis
Abstract Number: 26

Hints for Catecholamine-Driven Autocrine Mechanisms to Regulate Regulatory B Cells
Abstract Number: 2240

Hip Involvement in Patients with Gout: Results of an Ultrasound Study
Abstract Number: 1930

Histologic and Transcriptional Evidence of Subclinical Synovial Inflammation in Rheumatoid Arthritis Patients in Clinical Remission
Abstract Number: 1933

Histological Features and Tissue-Macrophage Phenotype of Synovial Biopsies Identify RA Patients in Sustained Remission at Risk of Disease Flare after Treatment Tapering or Discontinuation
Abstract Number: 44

Histone Deacetylase 1 (HDAC1): A Novel Therapeutic Target in Patients with Rheumatoid Arthritis
Abstract Number: 934

HIV Protease Inhibitors Cure Lupus-Prone Mice and Prevent T Helper 17 Cell-Driven Inflammation By Inhibiting CD95-Non-Apoptotic Signaling Pathway
Abstract Number: 1962

HLA Contributions to Risk and Protection for Anti-Centromere Autoantibody-Positive Scleroderma
Abstract Number: 1292

HLA-B*58:01 Genotype and the Risk of Allopurinol-Associated Severe Cutaneous Adverse Reactions in a Predominately Black or African American Population with Advanced Chronic Kidney Disease
Abstract Number: 1435

Hormonal Contraception Use and Capacity to Self-Screen for Contraindications Among Adolescents in a Pediatric Rheumatology Clinic
Abstract Number: 297

Hospitalization Rates Among Patients with Polymyalgia Rheumatica: A Population-Based Study from 1995-2017
Abstract Number: 1611

Hospitalizations for Serious Infections in Psoriatic Arthritis Patients: Data from the National Inpatient Sample 2000-2014
Abstract Number: 1177

How Are Patients with Chronic Musculoskeletal Pain Conditions Being Managed Initially in the U.S.?
Abstract Number: 1678

How Consistently Do Publications Define SLE? a Systematic Review
Abstract Number: 2373

How Do Patients Describe Their “New Normal” in Systemic Lupus Erythematosus? Use of Probabilistic Topic Modelling to Characterize Patients’ Experiences Recorded in an Online Health Community
Abstract Number: 2881

How Immunological Profile Drives Clinical Phenotype of Primary Sjögren’s Syndrome at Diagnosis: Analysis of 10.500 Patients (Sjögren Big Data Project)
Abstract Number: 515

How Knowledgeable Are Patients with Rheumatoid Arthritis about Cardiovascular Disease?
Abstract Number: 1556

How Phenotype of the Small Fibre Neuropathy in Primary Sjögren Syndrome Differs from Others Causes of Small Fibre Neuropathy ?
Abstract Number: 1787

How to Better Diagnose IgG4 Related Disease: a Single-Center Based Experience
Abstract Number: 637

How to Define Remission and Low Disease Activity in Psoriatic Arthritis? an Analysis of 419 Patients with a Double Perspective, Based on Composite Scores and Patients’ and Physicians’ Perspectives
Abstract Number: 545

How to Treat Rheumatoid Arthritis Patients When Methotrexate Has Failed? Results from the Meteor Registry
Abstract Number: 1051

Hoxd Genes Regulate Arthritis-Relevant Pathways
Abstract Number: 2088

Human TLR8 at the Interface between Innate and Adaptive Immunity in Systemic Lupus Erythematosus
Abstract Number: 2850

Human Toll-like Receptor 8 Adversely Affects Placental Development and Pregnancy Outcomes in a Mouse Model of Systemic Lupus Erythematosus
Abstract Number: 2102

Hyaluronic Acid Synthesis Inhibition Blocks Nephritis and Extends Lifespan in Mice Prone to Lupus
Abstract Number: 2628

Hydroxychloroquine and Prednisone Have Different Effects on Antiphospholipid Antibodies in SLE, with Hydroxychloroquine Not Reducing IgA Anticardiolipin
Abstract Number: 2668

Hydroxychloroquine and the Risk of Thrombotic Events in Systemic Lupus Erythematosus Patients : A Systematic Review and Meta-Analysis
Abstract Number: 2631

Hydroxychloroquine Blood Levels Are Significantly Associated with Cardiovascular Risk Factors
Abstract Number: 2897

Hydroxychloroquine Blood Levels Show Significant Trend Test for Risk of Retinopathy
Abstract Number: 2641

Hydroxychloroquine Could Modulate S100 Proteins Expression, Which Reflect the Activity of Lupus Nephritis or Skin Lesion, in Systemic Lupus Erythematosus Patients with Low Disease Activity
Abstract Number: 2637

Hydroxychloroquine Improves Disease Activity and Allows Reduction of Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus
Abstract Number: 1244

Hydroxychloroquine Quality Improvement Project at UF Health Jacksonville Rheumatology Clinics
Abstract Number: 1181

Hydroxychloroquine: Do We All See Eye to Eye? a Single-Site Analysis of Hydroxychloroquine Dosing Compared to 2016 American Academy of Ophthalmology Guidelines
Abstract Number: 1629

Hyperlipoproteinemia (a) in Patients with Spondyloarthritis. Results of the CARMA Study
Abstract Number: 236

Hypogammaglobulinemia and Infection Risk in Patients Treated with Rituximab
Abstract Number: 1080

Hypomethylation of STAT1 and HLA-DRB1 in CD8+ T Cells Is Associated with Type-I Interferon-Dependent HLA-DRB1 Overexpression and Activation of Autologous CD4+ T Cells in Systemic Lupus Erythematosus
Abstract Number: 117

Hypomorphic A20 Expression Modulates Fibrosis Susceptibility: Implications for Systemic Sclerosis?

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].